Document Detail

Approach to the patient with diabetes during pregnancy.
MedLine Citation:
PMID:  20685884     Owner:  NLM     Status:  MEDLINE    
The epidemics of obesity and type 2 diabetes mellitus (T2DM) globally are paralleling an increase in the number of women with T2DM becoming pregnant. Because T2DM is frequently undiagnosed before pregnancy, the risk of major malformations in the developing fetus is increased due to uncontrolled hyperglycemia. The lack of preconception care and the increase in complications of pregnancy due to the coexistence of obesity and T2DM are of concern from both an individual and a public health standpoint. Rapid achievement of normoglycemia with limited weight gain is critical to optimize maternal and fetal outcomes in all women with diabetes during pregnancy, regardless of the type of diabetes. This article will focus on T2DM preceding pregnancy due to its increasing prevalence and potentially dire fetal and maternal consequences. Euglycemia before, during, and after all pregnancies complicated by diabetes results in the best opportunity for optimal outcomes for mother and infant.
Jennifer Hone; Lois Jovanovic
Related Documents :
24588274 - Maternal and neonatal plasma microrna biomarkers for fetal alcohol exposure in an ovine...
23384584 - Maternal exposure to particulate air pollution and term birth weight: a multi-country e...
16329984 - The differential effect of realistic and unrealistic counterfactual thinking on regret.
3394754 - Diabetic nephropathy: pregnancy performance and fetomaternal outcome.
11325094 - Effects of fibrin glue on injured rabbit ureter.
12383554 - Problems with intrapartum fetal heart rate monitoring interpretation and patient manage...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  95     ISSN:  1945-7197     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-05     Completed Date:  2010-08-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3578-85     Citation Subset:  AIM; IM    
F.A.C.E., Sansum Diabetes Research Institute, 2219 Bath Street, Santa Barbara, California 93105, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Diabetes Mellitus, Type 2 / complications,  therapy*
Hyperglycemia / therapy*
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Obesity / complications
Pregnancy in Diabetics / therapy*
Treatment Outcome
Weight Gain
Reg. No./Substance:
0/Hypoglycemic Agents; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Update on estrogens and the skeleton.
Next Document:  Approach to the patient with incidental papillary microcarcinoma.